IPC names winner of 2015 Most Valuable Pharmacy award
SUN PRAIRIE, Wis. —The Independent Pharmacy Cooperative has selected Lombard Pharmacy and owner Craig Kueltzo as its 2015 Most Valuable Pharmacy.
Kueltzo, his family and the pharmacy staff received IPC’s MVP award on June 26 at the IPC Annual Business Meeting held during McKesson ideaShare 2015 in San Diego.
“It’s my pleasure to highlight the amazing work done by owner Craig Kueltzo and his pharmacy’s staff by awarding them IPC’s Most Valuable Pharmacy for 2015,” stated IPC president and CEO Don Anderson. “Lombard Pharmacy represents an essential business in the heart of its loyal community, relishes the importance of community leadership and promotes a business culture that always strives for excellence in customer service.”
IPC’s MVP Award recognizes a pharmacy that realizes the value of its extensive engagement within its cooperative. Lombard Pharmacy actively participates in various IPC initiatives and takes full advantage of the variety of IPC programs and services available to them, realizing the critical impact they have on the pharmacy’s operations.
“IPC’s allegiance is to independent pharmacy and promoting the future of independent pharmacy,” stated Kueltzo, who has also served on IPC’s advisory board. “I wouldn’t be without them, and our IPC membership has meant a lot to us over the years.”
At a special ceremony, Kuetlzo was surprised at the pharmacy on June 11 with a special acknowledgement ceremony involving a visit from IPC director of sales operations Mindy Herrmann.
“It’s truly humbling to receive this great award in front of my peers, family and staff,” Kueltzo stated. “It recognizes the wonderful work done by everyone here at Lombard Pharmacy, and it means a lot to me.”
IPC’s previous MVPs were: 2014: Tieton Village Drugs of Yakima, Wash.; 2013: Beemon Drugs of Jackson, Miss.; 2012: Yost Pharmacy of Mason, Ohio; 2011: Neuhauser Pharmacy of Madison, Wis.; 2010: Windham Pharmacy of Windham, N.Y.
Dating back to 1983, IPC has grown to be the nation's largest group purchasing organization, representing more than 2,500 members. With locations in Sun Prairie, Wis., and Phoenix, Ariz., IPC prides itself on providing access to programs and services to put profit back into the independent pharmacy.
Congratulations Craig from everyone at RxCherryPick. We've always known that your an award winning pharmacist. Best Regards Craig Robinson
FDA approves cystic fibrosis drug Orkambi
SILVER SPRING, Md. — The Food and Drug Administration recently approved Vertex Pharmaceuticals’ Orkambi (lumacaftor 200 mg/ivacaftor), a new cystic fibrosis treatment that received designation from the FDA as a breakthrough therapy and as an orphan drug.
Orkambi is specifically for individuals with cystic fibrosis with a mutation (F508del) that disrupts water and chloride transportation in the body by producing an abnormal protein. The leading cause of the disease is when an individual inherits one copy of this mutation from each parent.
“The FDA encourages manufacturers to develop new and innovative treatments for serious rare diseases like cystic fibrosis,” John Jenkins, director of the Office of New Drugs at the Center for Drug Evaluation and Research said. “Today’s approval significantly broadens the availability of targeted treatments for the specific defects that cause cystic fibrosis.”
The FDA approved Orkambi after a priority review, which is conducted in a shorter time than most reviews for drugs the agency believes can offer significant safety and efficacy improvements over currently available drugs.
No comments found
Rite Aid posts 2.4% in June same-store sales to kick off summer
No comments found